PT96291A - Processo para a preparacao de 1-(4-fluorofenil)-2-{4-{(4-metano-sulfonamido-fenil)-carbonil}-1-piperidinil}-etanona e 1-(4-fluorofenil)-2-{4-{(4-acetamidofenil)-carbonil}-1-piperidinil}-etanona uteis como agentes antitromboticos - Google Patents

Processo para a preparacao de 1-(4-fluorofenil)-2-{4-{(4-metano-sulfonamido-fenil)-carbonil}-1-piperidinil}-etanona e 1-(4-fluorofenil)-2-{4-{(4-acetamidofenil)-carbonil}-1-piperidinil}-etanona uteis como agentes antitromboticos

Info

Publication number
PT96291A
PT96291A PT96291A PT9629190A PT96291A PT 96291 A PT96291 A PT 96291A PT 96291 A PT96291 A PT 96291A PT 9629190 A PT9629190 A PT 9629190A PT 96291 A PT96291 A PT 96291A
Authority
PT
Portugal
Prior art keywords
fluorofenyl
ethanone
piperidinyl
carbonyl
acetamidofenyl
Prior art date
Application number
PT96291A
Other languages
English (en)
Other versions
PT96291B (pt
Inventor
Mark William Dudley
Albert Anthony Carr
Richard Cyrus Dage
John Ednar Koerner
Tung Li
Francis Peter Miller
Thaddeus Robert Nieduzak
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PT96291A publication Critical patent/PT96291A/pt
Publication of PT96291B publication Critical patent/PT96291B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT96291A 1989-12-21 1990-12-20 Processo para a preparacao de 1-(4-fluorofenil)-2-{4-{(4-metano-sulfonamido-fenil)-carbonil}-1-piperidinil}-etanona e 1-(4-fluorofenil)-2-{4-{(4-acetamidofenil)-carbonil}-1-piperidinil}-etanona uteis como agentes antitromboticos PT96291B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45449789A 1989-12-21 1989-12-21
US60465190A 1990-11-01 1990-11-01

Publications (2)

Publication Number Publication Date
PT96291A true PT96291A (pt) 1991-09-30
PT96291B PT96291B (pt) 1998-06-30

Family

ID=27037488

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96291A PT96291B (pt) 1989-12-21 1990-12-20 Processo para a preparacao de 1-(4-fluorofenil)-2-{4-{(4-metano-sulfonamido-fenil)-carbonil}-1-piperidinil}-etanona e 1-(4-fluorofenil)-2-{4-{(4-acetamidofenil)-carbonil}-1-piperidinil}-etanona uteis como agentes antitromboticos

Country Status (20)

Country Link
EP (1) EP0437790B1 (pt)
JP (1) JP2934323B2 (pt)
KR (1) KR0184641B1 (pt)
CN (1) CN1025853C (pt)
AR (1) AR247200A1 (pt)
AT (1) ATE133163T1 (pt)
AU (1) AU635098B2 (pt)
CA (1) CA2032797C (pt)
DE (1) DE69024933T2 (pt)
DK (1) DK0437790T3 (pt)
ES (1) ES2084642T3 (pt)
FI (1) FI96946C (pt)
GR (1) GR3018895T3 (pt)
HU (1) HU210590B (pt)
IE (1) IE71039B1 (pt)
IL (1) IL96731A (pt)
NO (1) NO176565C (pt)
NZ (1) NZ236501A (pt)
PT (1) PT96291B (pt)
TW (1) TW199145B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292752A (en) * 1989-12-21 1994-03-08 Merrell Dow Pharmaceuticals Inc. Antithrombotic compounds
ATE144899T1 (de) * 1990-06-07 1996-11-15 Merrell Pharma Inc Derivate des 1-piperidinyl- alkanoylarylsulfonamids
US5478846A (en) * 1990-06-07 1995-12-26 Merrell Dow Pharmaceuticals Inc. 1-piperidinyl alkanoylanyl sulfonamides for treatment of cardiac arrhythmia
EP0661266A1 (en) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
PH23283A (en) * 1986-02-26 1989-06-30 Eisai Co Ltd Piperidine derivative, pharmaceutical composition containing the same and method of use thereof
DE3750580T2 (de) * 1987-01-12 1995-05-24 Dominic A Ricchio Vorrichtung und verfahren zur verbesserten wassermassage.
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
US5064838A (en) * 1988-01-21 1991-11-12 Merrell Dow Pharmaceuticals 1,4-disubstituted-piperidinyl compounds as pain relievers
JP2969359B2 (ja) * 1989-01-13 1999-11-02 武田薬品工業株式会社 環状アミン化合物

Also Published As

Publication number Publication date
AR247200A1 (es) 1994-11-30
GR3018895T3 (en) 1996-05-31
FI96946B (fi) 1996-06-14
IL96731A (en) 1995-06-29
CA2032797C (en) 2002-03-19
EP0437790A3 (en) 1992-04-08
JPH04145068A (ja) 1992-05-19
FI906246A0 (fi) 1990-12-18
KR910011787A (ko) 1991-08-07
HU908370D0 (en) 1991-07-29
NO905511D0 (no) 1990-12-20
HU210590B (en) 1995-05-29
ES2084642T3 (es) 1996-05-16
DE69024933T2 (de) 1996-05-30
FI96946C (fi) 1996-09-25
AU635098B2 (en) 1993-03-11
NO905511L (no) 1991-06-24
DK0437790T3 (da) 1996-02-12
KR0184641B1 (ko) 1999-05-01
EP0437790A2 (en) 1991-07-24
PT96291B (pt) 1998-06-30
TW199145B (pt) 1993-02-01
ATE133163T1 (de) 1996-02-15
DE69024933D1 (de) 1996-02-29
NO176565B (no) 1995-01-16
NO176565C (no) 1995-04-26
AU6818190A (en) 1991-06-27
IE904632A1 (en) 1991-07-17
EP0437790B1 (en) 1996-01-17
NZ236501A (en) 1992-12-23
JP2934323B2 (ja) 1999-08-16
CN1025853C (zh) 1994-09-07
IE71039B1 (en) 1997-01-15
FI906246L (fi) 1991-06-22
CA2032797A1 (en) 1991-06-22
CN1052664A (zh) 1991-07-03

Similar Documents

Publication Publication Date Title
BR9001385A (pt) Aparelho e processo para uso na formacao de um eletrodo
PT91440A (pt) Processo para a preparacao de agentes anti-fungicos de triazole
KR920700231A (ko) 히알루론산 회합체를 함유하는 신규 조성물 및 그 제조방법
BR8907538A (pt) Processo e composicao de tecido para enxertos
BR9105078A (pt) Artigo isolante e processo para a preparacao do mesmo
BR8907085A (pt) Processo de preparacao de composicoes de betume-polimero
BR8906833A (pt) Composicao,processo para preparacao de compostos e aplicacao dos mesmos
BR9001314A (pt) Processo para preparacao de uma composicao de borracha e composicao de borracha
BR1100979A (pt) Derivado de carboidrato, processo para preparar um derivado de carboidrato, composição farmacêutica de carboidrato e uso de derivado de carboidrato
PT89344A (pt) Processo para a preparacao de composicoes fototranscromicas e dispositivos que as utilizam
BR9003296A (pt) Turbomaquina e processo para a operacao de uma turbomaquina
BR9004421A (pt) Composicoes anti-estaticas e amaciantes de tecidos e processo para amaciar e prover um acabamento anti-estatico a tecidos
PT94045A (pt) Processo para a preparacao de derivados de 2-piperidino-1-alcanol uteis como agentes anti-isquemicos
BR9003131A (pt) Processo e equipamento para a fragmentacao de material de moagem
BR8800334A (pt) Composicao e processo para amaciamento de tecidos
BR8806959A (pt) Composto e processo para a preparacao do mesmo
PT88814A (pt) Processo para a transformacao de lixos num material em forma de bolotas
PT91878A (pt) Processo para a preparacao de derivados do imidazole com propriedades hipocolesterolemicas e hipolipidemicas
PT91783A (pt) Processo para a preparacao de {(diarilmetoxi) alquil}-1-pirrolidinas e piperidinas
PT89195A (pt) Processo para a preparacao de derivados de triazole uteis como agentes anti-fungicos
BR8902843A (pt) Processo para preparacao de acidos(poli)peroxicarboxilicos heterociclicos tendo heteroatomo de nitrogenio amidico
BR8900098A (pt) Processo para a fabricacao de pisos para filtros e pisos construidos desse modo
BR8904212A (pt) Processo para preparar 1,3,5-trinitro-2,4,6-tripicrilbenzeno e composto
BR9000588A (pt) Processo para preparacao de copolimeros de propileno-etileno
BR9002451A (pt) Composicao e processo para preparar um composto

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910509

FG3A Patent granted, date of granting

Effective date: 19980330

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040930